You are here
AdvaMed Praises Successful USTR Enforcement Action Over China Export Subsidies
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), today issued the following statement following the U.S. Trade Representative’s successful challenge of China export subsidies in the World Trade Organization (WTO).
“AdvaMed applauds U.S. Trade Representative Ambassador Michael Froman for his insistence that China eliminate export subsidies provided under the country’s ‘Demonstration Bases-Common Services Platform Program.’ In successfully challenging this program in the WTO, Ambassador Froman demonstrated USTR’s commitment to enforcement of existing trade agreements.
“Under this program, China was providing millions of dollars’ worth of grants and discounted services – such as product design, testing and R&D services – to the country’s domestic companies, contingent on export, including services to over 100 medical technology firms. Not only did USTR’s action stop the current program, but it likely prevented even more Chinese government money from being poured into unfair competition against AdvaMed member companies.
“AdvaMed supports trade agreements that lower barriers to global markets and level the playing field for industry across borders to help ensure patient access to life-changing medical innovations. But enforcement is an essential element of these agreements, to stop unfair practices and ensure fair competition.”
# # #